ArticlePharmaceutical research2023

Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity.

Yeamin Huh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.